High-Throughput Epitope Discovery: Matrix Pooling vs. Individual Peptide Screening

Identifying minimal immunogenic peptide sequences within large viral proteomes, tumor neoantigens, or engineered biotherapeutic proteins presents a significant logistical and biological bottleneck. Screening hundreds of individual overlapping peptides one-by-one requires prohibitive quantities of precious donor PBMCs and extensive plate capacity.

To overcome sample volume constraints while preserving rigorous single-cell sensitivity, Creative Proteomics employs a structured Two-Step Two-Dimensional (2D) Peptide Matrix Pooling Strategy. By arranging 15-mer peptides (overlapping by 11 amino acids) into orthogonal intersecting row-and-column matrix pools, every individual peptide is represented in exactly one unique row pool and one unique column pool. A single primary ELISpot screening run identifies intersecting positive pools, which are subsequently confirmed in a focused secondary deconvolution assay using individual candidate peptides.

Key Advantages of Two-Dimensional Matrix ELISpot Mapping

  • Massive PBMC Conservation (80%+ Reduction): Reduces PBMC consumption from millions of cells down to manageable aliquots, enabling complete antigen scanning from a single donor blood draw.
  • Unbiased Epitope Coverage: Synthetic 15-mer peptides with 11-amino-acid overlaps ensure that all potential 8–10-mer MHC Class I (CD8+) and 12–16-mer MHC Class II (CD4+) core epitopes are captured.
  • High Signal-to-Noise Resolution: Automated spot counting with stringent background subtraction filters out non-specific stimulation and identifies true high-affinity T-cell clones.
  • Dual Th1 / Th2 / Cytotoxic Co-Mapping: Compatible with multi-color FluoroSpot to map cytokine polarization profiles (IFN-γ vs. IL-4 vs. Granzyme B) alongside epitope location.